结局变量,N,治疗效应系数,标准误,95%CI下限,95%CI上限,P值,R²,显著,控制变量,解释
ALT变化,281,0.8531084630401888,1.2749591901934816,-1.6568117329672625,3.3630286590476404,0.5039763899723576,0.10681902238931862,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组ALT变化无显著增加0.85单位
AST变化,281,0.7067374513725422,0.8494698549781033,-0.9655525805817393,2.3790274833268237,0.4061450739829878,0.10132726077234777,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组AST变化无显著增加0.71单位
肝硬度变化,219,-0.30203179210874814,0.4386662279898639,-1.1667148184948992,0.5626512342774028,0.4918727069705482,0.5591191557838981,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组肝硬度变化无显著减少0.30单位
